(CNN) – Hundreds of thousands of uninsured people may soon be able to access medication to prevent the HIV epidemic.
President Donald Trump and Health and Human Services Secretary Alex Azar announced on Twitter that the administration had worked with Gilead biotechnology company to secure a donation of HIV. prevention drug.
Truvada is PrEP prophylaxis or pre-exposure, which can prevent the transmission of HIV to those at risk of infection.
The donation "will help us achieve our goal of ending the HIV epidemic in America," Trump said.
Gilead said in a press release on Thursday that the company had agreed to provide up to 2.4 million Truvada bottles to the Disease Control Center every year. The drug will go to "uninsured Americans who are at risk for HIV," he said.
That will equate to supplying around 200,000 individuals each year for up to 11 years, and Azar said.
Although 1.1 million Americans are at risk for HIV, only about 200,000 currently receive Truvada, according to Gilead. Without insurance, the drug can run around $ 1,500 per month.
"Significant social and structural barriers, such as HIV stigma, homophobia, limited PrEP awareness among providers and patients, and a lack of access to healthcare in general, hinder a major barrier to endangered populations," said Gilead.
In the State of the Union address in February, President Trump called for the elimination of HIV transfers in the United States by 2030.
"We believe that today's donation, together with efforts to tackle the root causes of the epidemic, such as racism, violence against women, stigma, homophobia and transphobia, can play an important role in bringing the HIV epidemic to life. T in the US is over, especially in parts of the country with the greatest burden of disease, "Gilead said.